Continuous Glucose Monitoring (CGM) Adherence in Youth With Type 1 Diabetes: Associations With Biomedical and Psychosocial Variables
| Autor: | Rebecca K. Snelgrove, Lori M. Laffel, Lisa K. Volkening, Elisa Giani |
|---|---|
| Rok vydání: | 2016 |
| Předmět: |
Male
Pediatrics medicine.medical_specialty Adolescent endocrine system diseases Endocrinology Diabetes and Metabolism medicine.medical_treatment Biomedical Engineering 030209 endocrinology & metabolism Bioengineering 03 medical and health sciences 0302 clinical medicine Chart review Internal Medicine medicine Humans Psychology 030212 general & internal medicine Child Patient compliance Monitoring Physiologic Type 1 diabetes Special Section: Adherence and Diabetes Continuous glucose monitoring business.industry Insulin nutritional and metabolic diseases medicine.disease Diabetes Mellitus Type 1 Glucose Patient Compliance Female business Psychosocial |
| Zdroj: | Journal of Diabetes Science and Technology. 11:476-483 |
| ISSN: | 1932-2968 |
| DOI: | 10.1177/1932296816676280 |
| Popis: | Continuous glucose monitoring (CGM) remains underutilized in youth with type 1 diabetes (T1D). There is a need to investigate factors associated with CGM use.In 61 T1D youth, CGM use was ascertained by downloads reflecting the 4-week periods preceding 3- and 6-month study visits. Demographic and clinical data were obtained from chart review and interview. Youth and parents completed validated psychosocial surveys at baseline and 6 months.Youth (52% male, 93% Caucasian, 80% pump treated) were 12.7 ± 2.9 years old, with T1D for 6.3 ± 3.8 years; mean A1c was 7.9 ± 0.9%. Mean CGM use was 4.1 ± 2.1 days/week (median = 4.8) at 3 months and 3.4 ± 2.3 days/week (median = 3.9) at 6 months. At 3 and 6 months, 15% and 20% of youth, respectively, had stopped using CGM. At 6 months, youth using CGM 6-7 days/week had more frequent BG monitoring ( P = .05), less insulin omission ( P = .02), and greater probability of A1c7.5% ( P = .01) than youth using CGM less often. Youth using CGM 6-7 days/week consistently over the 6 months demonstrated lower A1c at 3 months compared to baseline ( P = .03) and the improvement was sustained at 6 months ( P = .5, 3 vs 6 months); youth using CGM less often had no significant A1c change. Baseline BG monitoring ≥8 times/day or A1c within target (7.5%) predicted greater CGM use (6-7 days/week) at 6 months (OR = 4.6, P = .02). There was no deterioration of psychosocial functioning with CGM use.Consistent and durable CGM use in youth with T1D is associated with treatment adherence and improved glycemic control without increasing psychosocial distress. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|